Aubrey Capital Management Ltd Makes New Investment in The Cigna Group (NYSE:CI)

Aubrey Capital Management Ltd purchased a new position in The Cigna Group (NYSE:CI) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 964 shares of the health services provider’s stock, valued at approximately $334,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Zions Bancorporation N.A. raised its stake in shares of The Cigna Group by 9.4% during the 3rd quarter. Zions Bancorporation N.A. now owns 943 shares of the health services provider’s stock worth $327,000 after acquiring an additional 81 shares in the last quarter. Huntington National Bank increased its position in shares of The Cigna Group by 2.5% during the third quarter. Huntington National Bank now owns 7,558 shares of the health services provider’s stock worth $2,618,000 after purchasing an additional 181 shares in the last quarter. Plato Investment Management Ltd lifted its holdings in shares of The Cigna Group by 4.5% during the 3rd quarter. Plato Investment Management Ltd now owns 14,727 shares of the health services provider’s stock valued at $5,097,000 after purchasing an additional 637 shares during the last quarter. Schrum Private Wealth Management LLC increased its holdings in shares of The Cigna Group by 19.7% during the third quarter. Schrum Private Wealth Management LLC now owns 758 shares of the health services provider’s stock valued at $263,000 after acquiring an additional 125 shares in the last quarter. Finally, Haverford Trust Co increased its stake in The Cigna Group by 6.0% during the 3rd quarter. Haverford Trust Co now owns 2,408 shares of the health services provider’s stock valued at $834,000 after purchasing an additional 136 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling at The Cigna Group

In other news, Director William J. Delaney III sold 2,691 shares of The Cigna Group stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $342.68, for a total value of $922,151.88. Following the sale, the director now owns 17,539 shares of the company’s stock, valued at $6,010,264.52. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.60% of the stock is owned by company insiders.

The Cigna Group Price Performance

Shares of NYSE CI opened at $331.75 on Thursday. The stock’s 50-day simple moving average is $340.14 and its 200-day simple moving average is $340.02. The firm has a market capitalization of $92.28 billion, a PE ratio of 31.30, a price-to-earnings-growth ratio of 1.02 and a beta of 0.51. The Cigna Group has a fifty-two week low of $253.95 and a fifty-two week high of $370.83. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.72 and a current ratio of 0.72.

The Cigna Group (NYSE:CI) last announced its earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.22 by $0.29. The firm had revenue of $63.70 billion during the quarter, compared to analysts’ expectations of $59.58 billion. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The business’s revenue was up 29.8% on a year-over-year basis. During the same period in the prior year, the firm earned $6.77 EPS. As a group, equities research analysts forecast that The Cigna Group will post 28.5 EPS for the current fiscal year.

The Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Wednesday, December 4th will be given a $1.40 dividend. This represents a $5.60 annualized dividend and a yield of 1.69%. The ex-dividend date is Wednesday, December 4th. The Cigna Group’s dividend payout ratio (DPR) is presently 52.83%.

Analysts Set New Price Targets

Several research firms have recently commented on CI. Barclays upped their price objective on shares of The Cigna Group from $405.00 to $420.00 and gave the company an “overweight” rating in a report on Tuesday, November 5th. StockNews.com downgraded shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Cantor Fitzgerald restated an “overweight” rating and set a $400.00 target price on shares of The Cigna Group in a research report on Wednesday, October 23rd. Royal Bank of Canada reduced their price target on The Cigna Group from $384.00 to $377.00 and set an “outperform” rating for the company in a report on Friday, November 1st. Finally, JPMorgan Chase & Co. upped their target price on The Cigna Group from $435.00 to $438.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 21st. One investment analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $394.64.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.